Cargando…

US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19

BACKGROUND: Favipiravir is used to treat influenza, and studies demonstrate that it has antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). METHODS: We performed a randomized, open-label, multicenter, phase 2 proof-of-concept trial of favipiravir in hospitalized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Finberg, Robert W, Ashraf, Madiha, Julg, Boris, Ayoade, Folusakin, Marathe, Jai G, Issa, Nicolas C, Wang, Jennifer P, Jaijakul, Siraya, Baden, Lindsey R, Epstein, Carol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651156/ https://www.ncbi.nlm.nih.gov/pubmed/34888401 http://dx.doi.org/10.1093/ofid/ofab563

Ejemplares similares

Colitis as a Sole Presentation of SARS-CoV-2 Infection: Case Report
por: Jaijakul, Siraya
Publicado: (2020)

844 The Clinical Significance of Cerebrospinal Fluid Neutrophilic Pleocytosis in Viral Central Nervous System Infections
por: Jaijakul, Siraya, et al.
Publicado: (2014)

Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials
por: Hayden, Frederick G, et al.
Publicado: (2022)

Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
por: Holubar, Marisa, et al.
Publicado: (2022)

In vitro proof of concept studies of radiotoxicity from Auger electron-emitter thallium-201
por: Osytek, Katarzyna M., et al.
Publicado: (2021)

Risk Factors for Admission Within a Hospital-Based COVID-19 Home Monitoring Program
por: Sperring, Heather, et al.
Publicado: (2022)

Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
por: Yamada, Kentaro, et al.
Publicado: (2016)

Clinical Outcomes of Prosthetic Knee Joint Infection in a United States Tertiary Healthcare Center
por: Ayoade, Folusakin, et al.
Publicado: (2017)

947. Stroke demographics and risk factor profile in HIV infected individuals in Florida
por: Ayoade, Folusakin, et al.
Publicado: (2020)

1481. Clinical profile of cerebral small vessel disease in people with HIV hospitalized for ischemic stroke
por: Ayoade, Folusakin, et al.
Publicado: (2023)

Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254( )
por: Spinner, Christoph D, et al.
Publicado: (2022)

A case of cerebral vasculitis due to neurobartonellosis
por: Poursheykhi, Meryim, et al.
Publicado: (2020)

Evaluation of Three Point-of-Care Tests for Detection of Toxoplasma Immunoglobulin IgG and IgM in the United States: Proof of Concept and Challenges
por: Gomez, Carlos A, et al.
Publicado: (2018)

A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease
por: Torrico, Faustino, et al.
Publicado: (2022)

Impact of a Multistep Bundles Intervention in the Management and Outcome of Gram-Negative Bloodstream Infections: A Single-Center “Proof-of-Concept” Study
por: Bavaro, Davide Fiore, et al.
Publicado: (2022)

Successful Proof-of-Concept for Topical Delivery of Novel Peptide ALM201 with Potential Usefulness for Treating Neovascular Eye Disorders
por: Obasanmi, Gideon, et al.
Publicado: (2022)

Relationship Between Anxiety, Depression, and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Proof of Concept
por: Vedhara, Kavita, et al.
Publicado: (2022)

Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia: A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial
por: Malchair, Pierre, et al.
Publicado: (2023)

“Holes” in the Jaw—A Report of Two Cases of Periapical Actinomycosis
por: Ayoade, Folusakin, et al.
Publicado: (2018)

Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell Transplant
por: Desjardins, Michaël, et al.
Publicado: (2021)

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
por: Sissoko, Daouda, et al.
Publicado: (2016)

Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever
por: Oestereich, Lisa, et al.
Publicado: (2016)

The Combined Effect of Oseltamivir and Favipiravir on Influenza A Virus Evolution
por: Ormond, Louise, et al.
Publicado: (2017)

Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
por: Sissoko, Daouda, et al.
Publicado: (2016)

Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
Publicado: (2016)

Disseminated Mycobacterium avium-Intracellulare Complex Infection Presenting With Disseminated Intravascular Coagulation in an AIDS Patient
por: Ayoade, Folusakin, et al.
Publicado: (2017)

Herpes Simplex Virus Proctitis Masquerading as Rectal Cancer
por: Ayoade, Folusakin, et al.
Publicado: (2019)

A case of rhino-orbital mucormycosis in an immunocompetent patient following Hurricane Irma
por: Ayoade, Folusakin, et al.
Publicado: (2019)

Immune Reconstitution Inflammatory Syndrome with Recurrent Paradoxical Cerebellar HIV-Associated Progressive Multifocal Leukoencephalopathy
por: Frattaroli, Paola, et al.
Publicado: (2021)

Properdin Levels in Individuals with Chemotherapy-Induced Neutropenia
por: Tsyrkunou, Artsiom, et al.
Publicado: (2016)

Sporotrichoid Skin Infection Caused by Nocardia brasiliensis in a Kidney Transplant Patient
por: Ayoade, Folusakin, et al.
Publicado: (2018)

Laboratory Findings, Compassionate Use of Favipiravir, and Outcome in Patients With Ebola Virus Disease, Guinea, 2015—A Retrospective Observational Study
por: Kerber, Romy, et al.
Publicado: (2019)

SEVERE SINUS BRADYCARDIA INDUCED BY FAVIPIRAVIR
por: Habib, Mhd Baraa, et al.
Publicado: (2021)

Partnering With State Health Departments to Address Injection-Related Infections During the Opioid Epidemic: Experience at a Safety Net Hospital
por: Burns, Rebecca H, et al.
Publicado: (2021)

Favipiravir inhibits acetaminophen sulfate formation but minimally affects systemic pharmacokinetics of acetaminophen
por: Zhao, Yanli, et al.
Publicado: (2015)

Memorandum 201
por: CERN. Geneva. Proton Synchrotron and Synchrocyclotron Committee
Publicado: (1984)

321. Clinical Characteristics of Hospitalized HIV Patients with COVID-19 in Miami
por: Ayoade, Folusakin, et al.
Publicado: (2021)

Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies
por: Sherman, Amy C, et al.
Publicado: (2022)

ICU admission and favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant Recipients
por: Kokogho, Afoke, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pr25b9snq77us208nqd1nl73id